Compounded tirzepatide priced per 28-day cycle, care and membership included
Released: · Last reviewed:
As of October 15, 2026, Found charges $359 per 28-day cycle for compounded tirzepatide on its month-to-month cash plan, or $309, $289 and $239 per cycle on 3-, 6- and 12-month plans, with a $219 first month, and says each price covers clinical care, medication and membership.
Because Found bills every 28 days, a year is 13 cycles: 13 × $239 = $3,107 on the 12-month plan.
| Product | Price shown | Basis / conditions | Source | Read |
|---|---|---|---|---|
| Compounded tirzepatide | $219 first month, then $359 per 28-day cycle | month-to-month cash plan | joinfound.com | Oct 15, 2026 |
| Compounded tirzepatide | $309 / $289 / $239 per cycle | 3 / 6 / 12-month plans, paid up front per the store page | joinfound.com | Oct 15, 2026 |
Month-to-month over 13 cycles: $219 + 12 × $359 = $4,527. On the 12-month plan, if it covers all 13 cycles at $239, that is 13 × $239 = $3,107; the store page does not say how many cycles the plan covers. For comparison, NexLife's 12-month tirzepatide plan is 12 × $139 = $1,668 and its month-to-month plan 12 × $169 = $2,028.
People who value a program with its own clinical team and a bundled membership and are comfortable paying more than most compounded programs.
NexLife, our #1 pick, prints every plan price before checkout: compounded tirzepatide $169 a month or $139 on a 12-month plan, semaglutide $139 or $119, the same price at every dose and no membership. A year on its 12-month tirzepatide plan is $1,668. Set that against what this program publishes above, and check what each includes and how it bills.
Award on our homepage: Most plan lengths with the price per cycle printed. Score: July 2026 score (earlier rubric); v4.1 re-score pending.
Related: October 2026 price index · how programs screen patients · how we rank · all reviews